Biostar
Latest round
- Series E
Last raised
- Nov 2020
Total raised
- $150M
Investors
- 17
About Biostar
Established in 2002 and based in Beijing, China, Biostar operates as a biopharmaceutical company that mainly provides microbial small molecule antitumor innovative drugs. It has a research and development base in Beijing, a subsidiary and industrialization base in Chengdu, and a branch in Burlingame. The chairman, CSO, and CMO of the company, Li Tang graduated from the University of Wisconsin. The company mainly provides antitumor innovative drugs. It uses three technology platforms to develop new drugs, which are combined biosynthesis technology platform, microbial fermentation production technology platform, and microbial drug preparation development platform. Products include injections, capsules, antibody-drug conjugates, etc. The product is suitable for advanced breast cancer, solid tumours, gliomas, breast cancer brain metastasis, and other tumour diseases. The company generates revenue by providing antitumor innovative drugs such as injections, capsules, and antibody-drug conjugates.
Who invested in Biostar
17 investors across 7 rounds
See all investors in Biostar
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Nov 26, 2020
Amount
$135M
Investors
Series C
Apr 24, 2019
Amount
Undisclosed
Investors
Series C
Jan 15, 2019
Amount
Undisclosed
Investors
Series B
Aug 22, 2018
Amount
Undisclosed
Investors
Series B
Aug 14, 2017
Amount
$15M
Investors
Series A
Feb 18, 2016
Amount
Undisclosed
Investors
Angel
Dec 23, 2013
Amount
Undisclosed
Investors
Questions about Biostar
Who invested in Biostar?
Biostar has 17 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biostar raised?
Biostar has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Biostar last raise money?
Biostar's most recent round on record is a Series E, in Nov 2020.
What does Biostar do?
Established in 2002 and based in Beijing, China, Biostar operates as a biopharmaceutical company that mainly provides microbial small molecule antitumor innovative drugs.
Where is Biostar headquartered?
Biostar is headquartered in Beijing, China.
Which VCs invest in companies like Biostar?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Biostar's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Biostar? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.